COVID-19 Vaccine Codes & RSV Vaccine Code

The U.S. Food and Drug Administration amended the emergency use authorizations of the Moderna and Pfizer-BioNTech COVID-19 bivalent mRNA vaccines to simplify the vaccination schedule for most individuals.
This action includes authorizing the current bivalent vaccines to be used for all doses administered to individuals 6 months of age and older, including for an additional dose or doses for certain populations. The monovalent Moderna and Pfizer-BioNTech COVID-19 vaccines are no longer authorized for use in the United States. 
The first respiratory syncytial virus (RSV) vaccine approved for use in the United States as well.
Below are the codes and information that can be utilized when seeing patients.


FDA Announcements:

Contact our Commercial Provider Service Center at 1-800-368-2312 for additional information.